Discover
CVAC
CureVac N.V.
4.66
2 x 3.32
2 x 5.37
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
4.62 -0.04 (0.86%)
| Ytd | 3.10% | |
| 1y | 28.73% |
4.57
day range
4.67
2.48
52 week range
5.72
| Open | 4.57 | Prev Close | 4.66 | Low | 4.57 | High | 4.67 | Mkt Cap | 929.96M |
| Vol | 1.13M | Avg Vol | 902.20K | EPS | 0.67 | P/E | 6.16 | Forward P/E | -7.07 |
| Beta | 1.77 | Short Ratio | 1.35 | Inst. Own | 10.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 5.27 | 200-d Avg | 4.69 | 1yr Est | 5.41 |
| Income Statement | |||
| Total Revenue | 54.13M | ||
| Revenues (USD) | 63.69M | ||
| Cost of Revenue | 375.00K | ||
| Gross Profit | 53.76M | ||
| Operating Expenses | -256.45M | ||
| Research and Development Expense | 38.25M | ||
| Selling, General and Administrative Expense | 25.43M | ||
| Operating Income | 310.21M | ||
| Interest Expense | 5.92M | ||
| Income Tax Expense | 34.35M | ||
| Net Income | 273.23M | ||
| Net Income Common Stock | 273.23M | ||
| Net Income Common Stock (USD) | 321.45M | ||
| Consolidated Income | 273.23M | ||
| Earnings per Basic Share | 1.21 | ||
| Earnings per Basic Share (USD) | 1.42 | ||
| Earnings per Diluted Share | 1.21 | ||
| Earning Before Interest & Taxes (EBIT) | 313.50M | ||
| Earning Before Interest & Taxes (USD) | 368.82M | ||
| Weighted Average Shares | 225.17M | ||
| Balance Sheet | |||
| Cash and Equivalents | 416.09M | ||
| Cash and Equivalents (USD) | 489.52M | ||
| Investments | 3.12M | ||
| Investments Current | 3.12M | ||
| Trade and Non-Trade Receivables | 19.60M | ||
| Current Assets | 873.11M | ||
| Property, Plant & Equipment Net | 235.60M | ||
| Total Assets | 1.14B | ||
| Debt Current | 4.76M | ||
| Total Debt | 35.07M | ||
| Current Liabilities | 236.17M | ||
| Debt Non-Current | 30.30M | ||
| Total Liabilities | 267.39M | ||
| Accumulated Retained Earnings (Deficit) | -1.24B | ||
| Accumulated Other Comprehensive Income | -309.00K | ||
| Shareholders Equity | 871.23M | ||
| Shareholders Equity (USD) | 1.02B | ||
| Assets Non-Current | 265.51M | ||
| Total Debt (USD) | 41.26M | ||
| Deferred Revenue | 955.00K | ||
| Goodwill and Intangible Assets | 24.68M | ||
| Inventory | 541.00K | ||
| Liabilities Non-Current | 31.22M | ||
| Trade and Non-Trade Payables | 8.72M | ||
| Tax Assets | 11.55M | ||
| Tax Liabilities | 42.31M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 4.36M | ||
| Net Cash Flow from Financing | -1.29M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 28.25M | ||
| Capital Expenditure | -242.00K | ||
| Issuance (Repayment) of Debt Securities | -1.29M | ||
| Net Cash Flow from Investing | -322.00K | ||
| Net Cash Flow from Operations | 29.86M | ||
| Effect of Exchange Rate Changes on Cash | -4.86M | ||
| Share Based Compensation | 1.45M | ||